A B S T R A C T The occurrence of a deficiency of adenosine deaminase (ADA) activity in some patients with severe combined immunodeficiency suggests a possible relationship between the activity of ADA and the aberration of the immune system. To help delineate the function of ADA in the immune response we have examined its role in monocyte maturation.
INTRODUCTION
A deficiency of the enzyme adenosine deaminase (adenosine aminohydrolase, EC 3.5.4.4, ADA) 1 has been found in the erythrocytes from a group of patients with severe combined immunodeficiency (1, 2) . Since a deficiency of this enzyme has not been found in the thousands of normal individuals screened for genetic purposes (3) , this suggests a causal relationship between the lack of ADA activity and an aberration of the immune system (1, 4) .
ADA catalyzes the irreversible deamination of adenosine to produce inosine and ammonia. This is an essential step in the adenosine cycle, which as a part of the purine salvage pathway enables the efficient reutilization (5) , and detoxification of adenosine (6, 7) .
An understanding of the function of ADA in cells in- volved in the immune response may clarify the relationship between a deficiency in this enzyme and the aberration of the immune system.
The involvement of the macrophage and its precursor, the monocyte (8) , in the normal immune response is well established (9, 10) . The monocyte normally comprises 3-7% of the total circulating leukocytes and has a half-life in the circulation of about 8 h (11) . In a response to inflammatory stimuli, monocytes migrate through capillary walls and enter the tissues where they may mature in size and complexity and become macrophages (12, 13) . The cells of the immune system by phagocytizing and degrading material recognized as foreign (10, 14) , and in the processing of antigens (9, 15 Total cell counts were performed in a hemocytometer after staining with Turk's stain, and viability of cells was determined by dye exclusion (0.1%o trypan blue).
The cell suspension was diluted with the culture medium to a density of 106 monocytes/ml and incubated in 1-ml FIGURE 1 Human monocyte cultured in vitro. Monocytes were isolated by centrifugation of leukocytes in a dense albumin gradient, and phase-contrast micrographs of unfixed preparations made (X 2,000). (A) Before cultivation. The nucleus is indented and a few small granules distributed in the cytoplasm. (B) After 72 h in culture. The nucleus is eccentrically located, and the enlarged cytoplasm is filled with large phase-dense lysosomal granules. Monocytes were cultured in RPMI 1640 with and without fetal calf serum (FCS). The activity of ADA was measured in the cell extracts (obtained as described in Table I ). The experiment was repeated three times with similar results. Cultures of monocytes obtained by albumin flotations were compared to those of highly purified monocytes obtained after cell adherence, and the results did not differ significantly. Therefore the adherence purification step was used only when the albumin flotation preparation was contaminated by 30%7 or more lymphocytes and for all experiments which were performed to study the molecular forms of the enzyme.
Cell processing. After various periods of incubation in vitro, cells were processed for morphological and biochemical studies as described below.
Cell suspensions were centrifuged at 4'C at 600 g for 10 min and resuspended in a small volume of culture medium. A drop from the concentrated suspension was used for morphological studies by phase-contrast microscopy using a Zeiss Ortholux microscope (Carl Zeiss, Inc., New York). The shape and position of the nucleus, the nuclear to cytoplasmic ratio, and cytoplasmic inclusions were recorded. For biochemical assays the cells were washed three times with phosphate-buffered saline; centrifugation was carried out at 4'C at 600 g for 10 min. The cell pellets, which were stored at -70'C for 24-72 h, were suspended in 400 ,ul ice-cold 0.01 M Tris-HCI pH 7.4 and lysed by freezing and thawing six times in liquid nitrogen. The suspension was centrifuged at 4'C at 6,600 g for 15 min, and the enzymatic activities were assayed in the supernate. Storing the cell pellets at -70'C did not affect the ADA activity and improved the extraction of the acid phosphatase.
Enzzpne assays. ADA was assayed by the conversion of [8-14C] adenosine to [8-"C]inosine as previously described (18) . ADA activity was linear with time and with protein concentration in both monocyte and macrophage extracts. The stability of the enzyme was studied in extracts of both cells, and neither was affected by incubation at 37'C for 2 h.
After dialysis, the activity of ADA in the extracts did not change significantly. Hypoxanthine-guanine phosphoribosyltransferase (EC 2.4.2.8) and adenine phosphoribosyltransferase (EC 2.4.2.7) were assayed by a radiochemical method as previously described (19 cytoplasm contained occasional vacuoles and only a few phase-dense granules (Fig. 1A) . By 8 h in culture, the cells had undergone morphological changes which became more prominent after 24 h. The nuclei became eccentrically located and the cytoplasm more abundant and filled with variable numbers of highly refractile lipid droplets and increasing numbers of phase-dense lysosomal (16) granules. By 72 h the monocytes acquired the typical morphology of macrophages, with the above changes being more accentuated and uniformly present (Fig. 1 B) . The increase in the number and size of lysosomal granules was accompanied by an increase in the cytochemically demonstrable activity of the lysosomal enzyme acid phosphatase. Cells stained by the azo dye method after 24 h in culture showed little or no reaction product, while after 48 h of cultivation many BLE (Fig. 2) . The specific activity of ADA increased two-to ninefold in the transforming monocytes (Fig. 2) . The increase could be detected as early as 3-4 h and reached a maximum after 16-24 h. There was no increase in the specific activity of the purine salvage pathway enzymes, adenine phosphoribosyltransferase, hypoxanthineguanine phosphoribosyltransferase, or adenosine kinase (Fig. 2) .
To determine whether the increase in ADA activity during maturation was due to the loss of an inhibitor or the appearance of an activator, a mixing experiment was performed. When extracts from monocytes before and after cultivation were mixed, the ADA activity equaled the arithmetic sum of the activities found in the individual extracts (Table I) .
Since a medium containing fetal calf serum exhibits low levels (< 0.01 Amol/h per mg protein) of ADA activity even after the heat treatment, we sought to exclude the possibility that the increase in ADA activity in the cells was due to ingestion of the enzyme from the medium. The cells were therefore cultured in medium devoid of serum. The viability of such cells started to decrease on the 2nd day in culture, however an increase in ADA specific activity comparable to that of control cultures was observed (Table II) . Molecular forms. The molecular forms of ADA were compared in extracts from monocytes before and after cultivation. Sucrose density ultracentrifugation of extracts from monocytes processed immediately after isolation revealed the presence of two forms of ADA with s.%,w values of 3.2 and 7.4, respectively (molecular weights of approximately 30,000 and 110,000). After 24 h in culture, the activity of the smaller molecular species increased (Fig. 3) and after 40 h, only the small form was found in the extracts.
Effect of puromycin. Table III summarizes the effect of puromycin on cultured monocytes. After 20 h in culture, puromycin had reduced the incorporation of [3H] leucine by 60%. The increase in ADA specific activity was blocked, and the morphological changes normally observed during maturation did not occur.
Effect of ADA inhibitor. When 0.3 mM EHNA was added to cell extracts, ADA activity was completely inhibited while the activities of adenosine kinase, adenine phosphoribosyltransferase, hypoxanthine-guanine phosphoribosyltransferase, or acid phosphatase were not affected (Table IV) . At this concentration of EHNA (0.3 mM), the normal morphological changes observed in maturing monocytes did not occur. During the first 3 days in culture in the presence of this inhibitor, there was no apparent increase in the cytoplasm, and only lipid droplets, numerous vacuoles, and a few phase-dense granules could be seen (Fig. 4) . By the 3rd day in culture 50% of the cells had died. When EHNA was removed after 24 h in culture, the monocytes underwent morphological changes that could not be distinguished from those observed in untreated cultures. When added during the 2nd day in culture, EHNA blocked the maturation of only 10-40% of the monocytes. However, most of the cells contained numerous vacuoles.
The effect of this potent and apparently specific inhibitor of ADA (27) a on monocyte maturation and viability is summarized in Table V. In the absence of EHNA the addition of adenosine (1 mM) had no apparent effect on monocyte maturation in culture as judged by morphological characteristics or the increase in acid phosphatase activity. Adenosine also had no discernible effect when the fetal calf serum was replaced with horse serum which is said to lack any detectable ADA activity (28) , thereby minimizing the possibility that the excess adenosine may be deaminated by the low levels of ADA activity in the medium. However, when adenosine was added concomitantly with EHNA (75 uM), most of the cells were dead within 3 days. This effect of adenosine was not prevented by the addition of 1 mM uridine and is thus unlikely to be due to pyrimidine starvation as described by Green and Chan (6) and Ishii and Green (28) .
In the presence of low concentrations of EHNA (75 oM) without the addition of adenosine, the cultured monocytes underwent morphological changes which could not be distinguished from those observed in the absence of the inhibitor. However, the ADA specific activity increased two-to ninefold during the early stages of monocyte to macrophage transition. This increase in activity was blocked by puromycin. While monocyte extracts contained two forms of ADA, the increase in ADA specific activity in macrophages correlated with an increase in the activity of only the smaller molecular species. The increase in ADA activity during monocyte maturation could be attributed neither to loss of an inhibitor nor development of an activator of the enzyme; when extracts from monocytes and macrophages were mixed, the ADA activity was equal to the arithmetic sum of the activities found in the individual extracts. The above results are consistent with the possibility that the increase in ADA activity might be due to a de novo synthesis of the enzyme. However, the possibility that the increase is a result of activation rather than synthesis cannot be excluded.
The increase in ADA activity is unlikely to be a nonspecific reflection of nucleic acid synthesis, for while the activity of this enzyme increases in the nondividing monocytes, it does not increase in phytohemagglutininstimulated lymphocytes during their transformation to actively dividing lymphoblasts (29) . Furthermore the increase in ADA activity in monocytes could not be attributed to a general increase in all enzymes involved in purine metabolism since no increase was found in the specific activity of another enzyme involved in the adenosine cycle, adenosine kinase, and in two other enzymes participating in the purine salvage pathway, hypoxanthine-guanine phosphoribosyltransferase, and adenine phosphoribosyltransferase. Finally, ADA does not appear to be associated with lysosomes (M. B. Van der Weyden, unpublished data); thus the increase in activity is not a reflection of the increased number of lysosomes.
Whatever the mechanism, the rapid and prominent increase in ADA activity triggered with the monocyte to macrophage transition suggests that ADA could have an important role in this process. This increase in ADA activity might be required to provide the cell with a mechanism for detoxifying adenosine. The effect of excess adenosine on cell viability and function has now been reported in several different cell types (6, 7, 28, 30, 31) . Green and Chan (6) have reported the toxicity of adenosine when added to established cultures of fibroblasts or lymphoid cells. They found that in the presence of 0.01-0.1 mM adenosine the cells die as a result of pyrimidine starvation. Lower concentrations of adenosine inhibit cell growth. The toxic effects were prevented by exogenous pyrimidine nucleotides such as uridine.
Normal monocytes are protected against the toxicity of excess adenosine even when added to the cultures at a concentration as high as 1 mM. This protection probably requires normal ADA activity in the cells, since inhibition of ADA by a specific inhibitor rendered the adenosine toxic and resulted in cytolysis. The ability of adenosine to cause cytolysis in monocyte cultures seems to be unrelated to the pyrimidine *starvation described by Green and Chan (6) since the effect was not prevented by the presence of excess uridine.
The studies with the ADA inhibitor, EHNA, suggest that ADA may be required for normal maturation of the monocytes. Low concentrations of the inhibitor prevented the increase in acid phosphatase specific activity. At higher concentrations, morphological changes of the cells associated with the maturation process were retarded but could be restored when EHNA was removed after the 1st day in culture. The rapid increase in the specific activity of ADA, which reaches its maximum during the 1st day in culture, suggests the involvement of ADA in the early stages of the maturation. This is further supported by the observation that the ADA inhibitor blocks the maturation of only a relatively small percentage of the monocytes when added to the cultures on the 2nd day.
Both Green and Chan (6) and Wolberg et al. (7) suggested that the accumulation of adenosine in lymphoid cells may contribute to the defective immune system associated with ADA deficiency. Our observations indicate that ADA might be important for normal macrophage function and that the abnormality of both humoral and cellular immunity in patients with ADA deficiency could be due, at least in part, to macrophage dysfunction.
